9-9:20am - Registration. Posters. Light Refreshments.

​

9:30-9:40am - Welcome and Introduction to the Symposium 

Maurizio Pellecchia, PhD., UC Riverside

Rodolfo Torres, PhD., VC Research & Economic Development, UC Riverside

​

9:40-9:50am - UC Drug Discovery Consortium: Introduction & Announcements

Michael A. Rogawski, PhD., UC Davis

​

Session I chair: Melanie Cocco, UC Irvine

​

9:50-10:15am - "Spatial Mapping of Organelle Networks and Metabolism in Lung Cancer"

David Shackelford, PhD., UC Los Angeles

​

10:15-10:40am - "The Development of Targeted Epigenetic Editors for the Treatment of Genetic Epilepsy"

Kyle Fink, PhD., UC Davis

​

10:40-11:05am - "Discovery of Antiviral Leads with Superior Efficacy in SARS-CoV2

and MERS Infection Models"

Adam Renslo, PhD., UC San Francisco

​

11:05-11:30am - "Massively Parallel, Single-Molecule Assessment of Synthetic Fidelity

and Drug-like Properties in DNA-encoded Library"

Scott Lokey, PhD., UC Santa Cruz

​

11:30am-1:30pm - Lunch and Poster Presentations (optional walks to either the botanical gardens or the MRB1 Incubator Laboratory Space)

​

Session II chairs: UCDDC EC

UC Translates round table session: From academic research to spin-off biotech companies

​

1:30-1:35pm - Armida Labs, UC Riverside spin-off

Carlo Baggio, PhD., Co-founder and CTO

​

1:35-1:40pm - Eicosis, UC Davis spin-off

Cindy McReynolds, PhD., CEO

​

1:40-1:45pm - Zenith Therapeutics, UC Berkeley spin-off

Julia Schaletzky, PhD., Co-founder

​

1:45-1:50pm - Amplyx Pharmaceuticals, UC San Francisco spin-off

Jason Gestwicki, PhD., Co-founder

​

1:50-1:55pm - Unnatural Products - UC Santa Cruz spin-off

Cameron Pye, PhD., Co-founder and CSO & Josh Schwochert, PhD., Co-founder and CTO

​

1:55-2:00pm - Ocean Therapeutics - UC San Diego spin-off

William Fenical, PhD., Founder

​

2:00-2:30pm - UC spin-off panel/roundtable discussion

​

2:30-2:55pm - Afternoon Break and Poster presentations

​

Session III chair: Robert Damoiseaux, PhD., UC Los Angeles

​

2:55-3:20pm - "The ESCRT system of membrane remodeling as a new target for drug discovery"

Jim Hurley, PhD., UC Berkeley

 

3:20-3:45pm - "Drugs Designed to Treat Sickle Cell Disease: Mechanisms of Binding to Hemoglobin"

Melanie Cocco, PhD., UC Irvine

 

3:45-4:10pm - "Covalent drug discovery targeting His/Lys or Tyr residues"

Maurizio Pellecchia, PhD., UC Riverside

        

4:10-4:15pm - Poster Awards

Maurizio Pellecchia, PhD.  and the UCDDC EC

       

Keynote presentation Chair, Michael Gilson, PhD., UC San Diego

 

4:15-5:00pm - "Angiogenesis: Basic Biology and Therapeutic Opportunities"

Keynote speaker, Napoleone Ferrara, MD., UC San Diego

 

5:00-5:30pm - Light refreshments and adjourn